JPMorgan Chase & Co. Has Lowered Expectations for Adient (NYSE:ADNT) Stock Price

Adient (NYSE:ADNTFree Report) had its price objective cut by JPMorgan Chase & Co. from $24.00 to $21.00 in a research report released on Monday morning,Benzinga reports. They currently have a neutral rating on the stock.

A number of other equities analysts also recently issued reports on the company. Bank of America downgraded Adient from a “buy” rating to a “neutral” rating and lowered their price target for the company from $30.00 to $24.00 in a report on Thursday, November 21st. StockNews.com lowered shares of Adient from a “buy” rating to a “hold” rating in a research note on Wednesday, January 22nd. Barclays decreased their price objective on shares of Adient from $24.00 to $21.00 and set an “equal weight” rating for the company in a research note on Wednesday, January 22nd. Wells Fargo & Company cut Adient from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $27.00 to $20.00 in a research report on Monday, December 16th. Finally, Morgan Stanley decreased their target price on Adient from $21.00 to $19.00 and set an “underweight” rating for the company in a research report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating and nine have issued a hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $22.38.

Check Out Our Latest Report on Adient

Adient Trading Up 0.9 %

NYSE ADNT opened at $17.30 on Monday. Adient has a 52 week low of $16.28 and a 52 week high of $36.04. The firm has a 50 day moving average of $18.05 and a two-hundred day moving average of $20.66. The company has a quick ratio of 0.90, a current ratio of 1.11 and a debt-to-equity ratio of 0.98. The stock has a market capitalization of $1.47 billion, a PE ratio of 75.22, a price-to-earnings-growth ratio of 0.28 and a beta of 2.16.

Adient (NYSE:ADNTGet Free Report) last posted its earnings results on Friday, November 8th. The company reported $0.68 EPS for the quarter, beating the consensus estimate of $0.56 by $0.12. The firm had revenue of $3.56 billion for the quarter, compared to analyst estimates of $3.47 billion. Adient had a return on equity of 6.86% and a net margin of 0.12%. Adient’s revenue for the quarter was down 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.51 earnings per share. As a group, research analysts expect that Adient will post 2.04 EPS for the current fiscal year.

Insider Activity at Adient

In other Adient news, EVP James Conklin sold 11,500 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total value of $232,875.00. Following the completion of the transaction, the executive vice president now directly owns 51,829 shares of the company’s stock, valued at approximately $1,049,537.25. This trade represents a 18.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On Adient

Institutional investors and hedge funds have recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC raised its position in Adient by 9.3% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 5,197,090 shares of the company’s stock worth $117,298,000 after acquiring an additional 442,200 shares during the last quarter. Pacer Advisors Inc. increased its position in Adient by 38,074.9% during the third quarter. Pacer Advisors Inc. now owns 5,144,445 shares of the company’s stock worth $116,110,000 after buying an additional 5,130,969 shares in the last quarter. State Street Corp raised its holdings in shares of Adient by 4.8% in the third quarter. State Street Corp now owns 3,443,471 shares of the company’s stock worth $77,719,000 after acquiring an additional 158,017 shares during the last quarter. Pzena Investment Management LLC lifted its position in shares of Adient by 45.0% in the third quarter. Pzena Investment Management LLC now owns 2,825,491 shares of the company’s stock valued at $63,771,000 after acquiring an additional 877,142 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Adient by 6.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 963,446 shares of the company’s stock valued at $21,745,000 after acquiring an additional 55,387 shares during the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

Adient Company Profile

(Get Free Report)

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Recommended Stories

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.